At TotemID Biosciences, we are expanding the scope of what is possible with at-home health testing. We have a fully issued patent for a bioassay platform technology based on cutting edge advances in nucleic acid nanotechnology, which can be adapted to detect various pathogens and biomarkers of health status. Furthermore, we combine this technology with a data-driven R&D framework designed to leverage large-scale biobank data and machine learning to develop next generation at-home screening and diagnostic tests for complex conditions such as Alzheimer’s disease, cancers, and even aging. Our initial product will be a multi-respiratory pathogen test for detecting COVID-19 and Influenza A/B, one of the first at-home tests of its kind.